Accepted Manuscript The Incidence of Prostate Cancer in Iran: A Systematic Review and Meta-analysis Soheil Hassanipour, Mohammad Fathalipour, Hamid Salehiniya PII:
S2287-8882(17)30126-5
DOI:
10.1016/j.prnil.2017.11.003
Reference:
PRNIL 117
To appear in:
Prostate International
Received Date: 9 October 2017 Revised Date:
28 October 2017
Accepted Date: 30 November 2017
Please cite this article as: Hassanipour S, Fathalipour M, Salehiniya H, The Incidence of Prostate Cancer in Iran: A Systematic Review and Meta-analysis, Prostate International (2018), doi: 10.1016/ j.prnil.2017.11.003. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
The Incidence of Prostate Cancer in Iran: A Systematic Review and Meta-analysis Short Title: Prostate Cancer in Iran
RI PT
Soheil Hassanipour1, Mohammad Fathalipour1, Hamid Salehiniya2,3
AC C
EP
TE D
M AN U
SC
1) Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran 2) Zabol university of Medical Sciences, Zabol, Iran. 3) Department of Epidemiology and Biostatistics , Tehran University of medical sciences, Tehran, Iran( Correspond Author, email:
[email protected])
ACCEPTED MANUSCRIPT
Title: The Incidence of Prostate Cancer in Iran: A Systematic Review and Meta-analysis Short Title: Prostate Cancer in Iran
RI PT
Abstract
SC
Background: Prostate cancer is one of the most common cancers among men. There are various estimates of prostate cancer incidence from different geographical areas in Iran. Also, no systematic reviews are available regarding the incidence rate of prostate cancer in Iran. Thus, the present systematic review aimed to address this epidemiological gap.
TE D
M AN U
Method: This systematic review was performed based on the preferred reporting items for systematic reviews and meta-analysis (PRISMA) in July 2017. In doing so, the researchers searched Medline/PubMed, Scopus, Embase, ScienceDirect, and Google Scholar for international papers and four Iranian databases (Scientific Information Database, MagIran, IranMedex, and IranDoc) for Persian articles.
AC C
EP
Result: A total of 274 titles were retrieved in the initial search of the databases. Further refinement and screening of the retrieved studies produced a total of 21 studies. Based on the random effect model, the age-standardized rate (ASR) of prostate cancer was 9.11, 95% CI (8.19 to 10.04). Besides, the results of Cochran’s test indicated the heterogeneity of the studies (Q=1457.8, df =46.0, I2=96.8%, p0.1 and I2
